| Company Name: |
BOC Sciences |
| Tel: |
16314854226 |
| Email: |
inquiry@bocsci.com |
1-beta-D-Ribofuranosyl-4(1H)-pyrimidinone manufacturers
- 2-Deoxyuridine
-
- $1880.00
-
2026-05-19
- CAS:21052-20-0
- Purity:
- Supply Ability: 10g
|
| | 1-beta-D-Ribofuranosyl-4(1H)-pyrimidinone Basic information |
| Product Name: | 1-beta-D-Ribofuranosyl-4(1H)-pyrimidinone | | Synonyms: | 1-beta-D-Ribofuranosyl-4(1H)-pyrimidinone;2-Deoxyuridine, 1-(b-D-ribofuranosyl)-4-pyrimidinone;4(1H)-Pyrimidinone, 1-β-D-ribofuranosyl-;1-?β-?D-?ribofuranosyl-4(1H)?-?Pyrimidinone | | CAS: | 21052-20-0 | | MF: | C9H12N2O5 | | MW: | 228.2 | | EINECS: | | | Product Categories: | | | Mol File: | 21052-20-0.mol |  |
| | 1-beta-D-Ribofuranosyl-4(1H)-pyrimidinone Chemical Properties |
| Boiling point | 499.0±55.0 °C(Predicted) | | density | 1.73±0.1 g/cm3(Predicted) | | pka | 12.94±0.70(Predicted) |
| | 1-beta-D-Ribofuranosyl-4(1H)-pyrimidinone Usage And Synthesis |
| Uses | 2-Deoxyuridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | | References | [1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
| | 1-beta-D-Ribofuranosyl-4(1H)-pyrimidinone Preparation Products And Raw materials |
|